MindGenix

MindGenix is a specialized biotechnology and contract research organization (CRO) focused on the discovery and development of treatments for Central Nervous System (CNS) disorders. The company leverages advanced behavioral pharmacology and neuroimaging techniques to evaluate the efficacy of novel compounds in neurodegenerative and psychiatric conditions. MindGenix provides a range of preclinical services, including in vivo disease modeling and pharmacokinetic analysis, to support drug development pipelines. By integrating deep neuroscience expertise with proprietary screening platforms, the company aims to accelerate the transition of CNS candidates from discovery to clinical application.